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Abbreviations and Symbols 
 
a.a. amino acids 
AMPK adenosine monophosphate-activated protein kinase 
bHLH basic helix loop helix 
BMAL1 brain and muscle ARNT like 1 
CLOCK circadian locomotor output cycles kaput 
CO carbon monoxide 
CKI casein kinase I 
CRY cryptochrome 
DBP D-site of albumin promoter binding protein 
DTT dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
EMS electrophoretic mobility shift 
FBXL F-box and leucine-rich repeat protein 
HAT histone acetyltransferase 
IPTG isopropyl-β-D-thiogalactopyranoside 
KD dissociation constant 
NAAD nicotinic acid adenine dinucleotide 
NAD(H) nicotinamide adenine dinucleotide (reduced form) 
NADP(H) nicotinamide adenine dinucleotide phosphate (reduced form) 
NAMPT nicotinamide phosphoribosyltransferase 
NO nitric oxide 
NPAS2 neuronal PAS domain protein 2 
OD optical density 
PER period 
PMSF phenylmethanesulfonyl fluoride 
ROR retinoic acid receptor-related orphan receptor 
SCN suprachiasmatic nucleus 
SIRT1 sirtuin 1 
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Chapter 1. 
General introduction 
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Circadian rhythms are intrinsic mechanisms to adopt the environmental change 
occurred by the rotation of Earth, which are highly conserved in organisms ranging 
from cyanobacteria to humans. These rhythms have general characteristics that they 
autonomously continue in about 24 hour period even in constant darkness, have 
temperature-compensated periodicity and could be entrained by the environmental 
signals. In mammals, circadian rhythms control behavioral and physiological events 
such as the sleep-wake cycle, locomotor activity, body temperature, hormone release 
and metabolism. The master clock of mammalian circadian rhythms exists in the 
suprachiasmatic nucleus (SCN) which consists of twenty thousands of neuronal cells 
located at the hypothalamus, and it coordinates peripheral clocks that exist in most 
tissues such as lung, heart, liver, and kidney. Tissue destruction experiments revealed 
that the SCN clock was entrained by light input signal via retinohypothalamic tract, 
while restricted feeding experiments revealed that peripheral clocks were entrained by 
food intake signal in addition to the entrainment by the SCN clock [1]. 
At the molecular level, the breakthrough in the understanding of circadian clock 
was brought about by the discovery of clock genes defined as being necessary to 
generate normal circadian rhythms (Figure 1-1). It is currently known that the 
intracellular positive and negative transcriptional/translational feedback loops of clock 
genes and proteins generate the oscillations of circadian clocks [2-4]. As positive 
components of core loop, CLOCK and BMAL1 form a heterodimer to activate the 
transcription of various genes, including Pers and Crys, via E-box sequence in the 
promoter/enhancer region of these genes. Translated PERs and CRYs proteins, as the 
negative components of the clock machinery, form dimers or a large complex, are 
translocated into the nucleus, and eventually inhibit the transcriptional activity of 
CLOCK and BMAL1 [5-7]. 
In addition to this core loop, the orphan nuclear receptors RORs and Rev-erbs 
play important roles in the establishment of the more robust circadian clock. RORs and 
Rev-erbs, respectively, enhance and inhibit the transcription of Clock and Bmal1 genes 
via RORE sites [8-11]. DBP and E4BP4, other clock proteins that are regulated their 
own transcription via E-box and RORE, respectively, make supporting loops by 
accelerating and inhibiting the transcription of clock genes via D-box sequence, 
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respectively. DEC1 and DEC2, members of the bHLH transcription factor superfamily, 
also form a supporting negative feedback loop for their own transcription via E-box 
sequence, while the transcription of Dec1 and Dec2 are also under the control of 
RORE [12]. 
Further, the circadian clock generated by these transcriptional feedback loops is 
affected by various environmental stimuli, including light, foods and hormones [13-15]. 
In response to light signal, glutamate and pituitary adenylate cyclase-activating 
polypeptide (PACAP) are released to SCN neuron, which is sequentially followed by 
the elevation of cAMP level in the SCN and the activation of cAMP response 
element-binding protein (CREB). An acute induction of Per1 gene is caused by CREB 
via cAMP response element (CRE) in the Per1 promoter and finally the phase shift of 
the clock is achieved [16]. On the other hand, intracellular concentrations of NAD
+
 and 
heme, ligands of SIRT1 and Rev-erbs, respectively, impact on the circadian clock by 
the regulation of activities of these proteins, whereas the concentrations of these 
metabolites oscillate in a circadian fashion [17-19]. Moreover, glucocorticoid, a steroid 
hormone released from the cortex of the adrenal gland, activates glucocorticoid 
receptors that in turn bind to glucocorticoid response elements (GREs) in Per1 and 
Per2 genes, regulate their transcription, and reset the clocks in the peripheral tissues 
[20, 21]. It is also known that treatment with dexamethasone, a synthetic 
glucocorticoid, could synchronize the expression rhythms of several clock genes in 
individual cultured cells. 
The clock proteins are also regulated at the post-transcriptional level, such as 
phosphorylation, sumoylation and ubiquitylation, to ensure the maintenance of 
circadian rhythms [22-29]. For example, AMP protein kinase (AMPK) and casein 
kinase Iε (CKIε) play essential roles in the turnover of CRY1 and PER1, respectively, 
by phosphorylating and decreasing their stability [25, 28]. In addition, a component of 
the Skp1-Cul1-F-box protein (SCF) ubiquitin ligases, F-box and leucine-rich repeat 
protein 3 (FBXL3) and β-transducin repeat-containing protein (β-TRCP), form 
SCF
FBXL3
 and SCF
β-TRCP
 complexes to promote the ubiquitylation of phosphorylated 
CRY1 and PER1, respectively, and degrade these proteins via ubiquitin-proteasome 
pathway [25, 29]. 
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Thus, various types of clock genes and proteins have been reported to date, and 
the understanding of their rigorous and concerted regulatory mechanisms for circadian 
clock is accelerating [30]. Furthermore, in recent years, accumulating evidences have 
demonstrated that the disruption of circadian clock causes or is related to many kinds 
of disease including mental disorder, diabetes, myocardial infarct, metabolic syndrome 
and cancer. Therefore, to establish the therapeutic methods of these diseases, further 
elucidation of molecular clockworks at the atomic level is required. 
 
Figure 1-1. The circadian network of clock genes and proteins. The red and blue lines 
indicate positive and negative limbs, respectively. RORE, ROR binding element; E, 
E-box; D, D-box. 
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Neuronal PAS domain protein 2 (NPAS2), the subject of this thesis, is a core 
transcriptional activator regulating circadian rhythms. NPAS2 was originally isolated as 
a homolog of CLOCK in the mammalian forebrain [31, 32], but is also known to be 
expressed in the peripheral tissues [33, 34]. NPAS2, similar to CLOCK, forms a 
heterodimer with BMAL1 that binds to E-box sequences (CACGTG) or E-box like 
sequence (CACGTT) located in the regulatory regions of numerous clock genes and 
clock controlled genes to enhance their transcription [6, 32, 35]. Recently, chromatin 
immunoprecipitation sequencing (ChIP-seq) analyses have shown that there were about 
2,300 of the DNA-binding sites for NPAS2 in murine liver, whereas about 4,600 and 
5,900 sites for CLOCK and BMAL1, respectively [36]. Although the analyses of 
knockout mice revealed an overlapping role of CLOCK and NPAS2 in the circadian 
clock [33, 34], Npas2-deficient mice showed particular difficulty in their adaptability to 
food restriction and sleep homeostasis [33, 37]. A specific role of NPAS2 in metabolism 
has also been supported by the observations that single-nucleotide polymorphisms 
(SNPs) in Npas2 have been linked to increased risks of cancer, metabolic syndrome and 
hypertension [38-40]. In addition, several genes involved in tumorigenesis were actually 
confirmed to be direct targets of NPAS2, and it was proposed that NPAS2 was a risk 
marker for cancer as well as a tumor suppressor [38, 40]. Therefore, it is particularly 
interesting to elucidate the regulation mechanism of NPAS2 function. 
NPAS2 consists of a bHLH domain and two PAS domains (PASA and PASB) in 
the N-terminal half, and a transactivation domain in the C-terminal half. A bHLH 
domain is a protein structural motif which is characterized as a highly conserved 
DNA-binding domain and forms functional homodimer or heterodimer complexes with 
other bHLH proteins [41-43]. CACGTG (E-box) and CACGTT (E-box like) were 
demonstrated to be recognized by the bHLH domain of NPAS2, while in addition to 
these sequences, CACGNG and CATG(T/C)G were reported to be functional binding 
motifs for that of CLOCK [44]. On the other hand, PAS domains have now been 
observed in over 2,000 proteins, including kinases, transcription factors, ion channels 
and other enzymes that have diverse functions in signal transduction, protein-protein 
interactions and transcription [45, 46]. In NPAS2, each PAS domain binds heme as a 
prosthetic group with 1:1 stoichiometry, and the binding of CO and NO to the ferrous 
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heme regulates the DNA-binding activity of the NPAS2/BMAL1 heterodimer [47-49]. 
Since the binding affinity of CO to PASA-heme is about 10-fold greater than that to 
PASB-heme, the PASA domain is thought to act as a main gas sensor [47]. Additionally, 
previous study of resonance Raman spectra demonstrated that His119 and His171 were 
axial ligands of the ferric and ferrous heme in the isolated bHLH-PASA domain of 
NPAS2 [50]. 
Besides these features, it has also been suggested that the DNA-binding activity of 
NPAS2 is regulated by the intracellular redox state of NAD(P)H, although the 
mechanism remains unclear (Figure 1-2) [51]. In the chapter 2, therefore, to investigate 
the NAD(P)H interaction site of murine NPAS2, electrophoretic mobility shift (EMS) 
assays were performed using several truncation mutants of the NPAS2 bHLH domain. 
Furthermore, during these studies, it was also found that the complex formation of the 
NPAS2/BMAL1 heterodimer with DNA was affected by pH. In the chapter 3, the 
effects of pH on the DNA-binding activity and the transcriptional activity of NPAS2 
were investigated in an EMS assay and a luciferase assay, respectively. 
 
 
Figure 1-2. Proposed signals sensed by NPAS2. A heme binds PASA and PASB 
domains of NPAS2 reversibly. CO and NO bind ferrous heme of PAS domains of 
NPAS2, and CO-binding to the PASA ferrous heme inhibits the DNA-binding activity 
of NPAS2, whereas the effect of NO remains unclear. The effects of pH and NAD(P)H 
on the DNA binding activity of NPAS2 are described in this thesis. ccg, clock controlled 
genes.  
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Chapter 2. 
Effects of NAD(P)H on the DNA-binding activity of NPAS2 
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2-1. Introduction 
 
Circadian rhythms are fundamental mechanisms observed in almost all living 
organisms including cyanobacteria, drosophila, arabidopsis and humans. These rhythms 
control behavioral and physiological phenomenon, which are entrained by the daily 
light-dark cycle in a 24 hour period. In mammals, the master clock of circadian rhythms 
exists in the suprachiasmatic nucleus (SCN), and it coordinates peripheral clocks that 
exist in most tissues. At the molecular level, it is known that the intracellular positive 
and negative transcriptional/translational feedback loops of clock genes and proteins 
generate the oscillations of circadian clocks [1, 2, 4]. 
Neuronal PAS domain protein 2 (NPAS2) is a transcription factor associated with 
mammalian circadian rhythms, and it was originally identified as a homolog of 
CLOCK [32]. NPAS2 also forms a heterodimer with BMAL1 that binds to E-box 
sequences located in the promoter regions of Per and Cry genes and enhances their 
transcription. When PER and CRY proteins accumulate, they negatively regulate their 
own expression by inhibiting NPAS2/BMAL1 heterodimer. Although NPAS2 and 
CLOCK exhibit overlapping functions, NPAS2-deficient mice show particular 
difficulty in their adaptability to food restriction and sleep homeostasis [33, 37]. 
NPAS2 belongs to the bHLH-PAS superfamily and contains a bHLH domain, two PAS 
domains (PASA and PASB) and a transactivation domain. A bHLH domain is a basic 
DNA-binding domain that forms functional homodimer or heterodimer complexes 
with other bHLH proteins [41-43], while a PAS domain is a multifunctional protein 
domain that is contained in a large number of proteins [45, 46]. In NPAS2, each PAS 
domain binds heme as a prosthetic group, and the PASA domain acts as a gas sensor to 
regulate the DNA-binding activity of the NPAS2/BMAL1 heterodimer by CO and NO 
binding to the ferrous heme [47-50]. 
It was reported that NADH and NADPH enhanced the DNA-binding activity of 
the NPAS2/BMAL1 heterodimer, whereas NAD
+
 and NADP
+
 inhibited its activity, 
suggesting regulation by the redox state of the NAD cofactors [51]. These NAD 
cofactors are well known as essential electron carriers used in a huge number of 
metabolic pathways including glycolysis, TCA cycle, β-oxidation, and biosynthesis of 
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fatty acids, sterols and nucleotides. Since these processes is closely related to feeding, 
the regulation of circadian clock by the NAD cofactors is very interested finding as the 
evidence for the food entrainment of circadian rhythms, although it has already been 
accepted the idea that the circadian rhythms control the feeding behavior of animals. 
In the report by Rutter et al., the N-terminal 116 amino acids (a.a.) of murine 
NPAS2 and a.a. 75-126 of human BMAL1 were demonstrated to be sufficient for 
responsiveness to NAD(P)H [51]. However, their precise interaction sites and 
mechanisms remain unclear. Therefore, various truncated NPAS2 proteins were 
generated and electrophoretic mobility shift (EMS) assays were performed to examine 
how their DNA-binding activities were affected by NAD(P)H and its derivatives. 
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2-2. Materials and methods 
 
2-2-1. Construction of expression plasmids 
The expression plasmid for His-tagged murine NPAS2 bHLH-PASA (1-240 a.a.) 
was previously constructed [52]. The corresponding cDNA was cloned into the Nde I 
and Sal I sites of an E. coli expression vector, pET-28a(+) (Novagen), which introduced 
6 × His-tag at the N-terminal of expressed proteins. To create the C-terminal truncation 
mutants of NPAS2 bHLH-PASA, NPAS2 bHLH (1-116 a.a.), bHLH (1-79 a.a.) and 
bHLH (1-61 a.a.), PCRs were performed using pET-28a(+) containing NPAS2 
bHLH-PASA cDNA as the template. The primers used for PCR were 
5’-CGGGATCCCATATGGACGAAGATGAGAAG-3’ as a sense primer for all mutants 
and 5’-CCCGTCGACCTAGAGAGGTGTGATAC-3’, 
5’-CCCGTCGACCTAGAATGATGGCTTCC-3’ and 
5’-CCCGTCGACCTATTCATTGTGTTTCTG-5’ as antisense primers for NPAS2 
bHLH (1-116 a.a.), bHLH (1-79 a.a.) and bHLH (1-61 a.a.), respectively. The resulting 
products were subcloned into the Nde I and Sal I sites of pET-28a(+). 
The expression plasmid for MBP-tagged murine BMAL1 bHLH-PASA-PASB 
(1-447 a.a.) was previously constructed [52]. The corresponding cDNA was cloned into 
the BamH I and Sal I sites of an E. coli expression vector, pMAL-c2X (New England 
Biolabs), which introduced MBP-tag at the N-terminal of expressed proteins. To create 
BMAL1 bHLH-PASA (74-336 a.a.), PCR was performed using pMAL-c2X containing 
BMAL1 bHLH-PASA-PASB cDNA as the template. The primers used for PCR were 
5’-CAGGATCCAGGGAGGCCCACAGTC-3’ as a sense primer and 
5’-CGAGTCGACTATTTCACCCGTATTTCCCC-3’ as an antisense primer. The 
resulting product was subcloned into the BamH I and Sal I sites of pMAL-c2X. 
All of the desired constructs were confirmed by sequencing. The domain 
structures of these proteins are shown in Figure 2-1. 
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2-2-2. Expression and purification of the isolated bHLH-PASA and bHLH proteins of 
NPAS2 
Expression and purification of the isolated bHLH-PASA or bHLH proteins of 
NPAS2 were performed essentially based on the method as described [49, 52]. E. coli 
BL21-CodonPlus (DE3)-RIL cells (Stratagene) were transformed with pET-28a(+) 
containing cDNA of NPAS2 bHLH-PASA or each cDNA of NPAS2 bHLH truncation 
mutants. The colonies were selected on a LB agar plate containing 30 μg/ml kanamycin 
and 35 μg/ml chloramphenicol. The cells were inoculated in TB medium containing the 
same antibiotics after preincubation of a single colony in LB medium and incubated at 
37°C until the OD600 reached to 0.6. Then 0.05 mM IPTG was added into the medium to 
induce the protein expression after cooling down to 15°C and the culture continued for 
further 20 h with mild shaking. 
The cells expressing each NPAS2 protein were collected by centrifugation and the 
cell extract was prepared by sonication in buffer A (50 mM sodium phosphate, pH 7.8, 
50 mM NaCl, 10% glycerol, 2 μg/ml aprotinin, 2 μg/ml leupeptin, 2 μg/ml pepstatin A, 
1 mM PMSF and 0.2 mM DTT). After ultracentrifugation, the supernatant was applied 
to a Ni-NTA agarose column (Qiagen) pre-equilibrated with buffer A. The column was 
washed sequentially with buffer A containing 20 mM and 70 mM imidazole for 
His-NPAS2 bHLH-PASA or 50 mM and 100 mM imidazole for His-NPAS2 bHLH 
truncation mutants. His-NPAS2 bHLH-PASA and truncation mutants were then eluted 
with buffer A containing 150 mM and 250 mM imidazole, respectively. The protein 
fractions were pooled, concentrated and applied to a Sephadex G-25 column (GE 
Healthcare) pre-equilibrated with buffer B (50 mM HEPES, pH 7.5, 10% glycerol and 1 
mM DTT) to remove imidazole and for buffer exchange.  
His-NPAS2 bHLH-PASA was prepared as holo-protein by reconstitution with two 
equivalents of hemin (2.5 mM stock in 0.01 N NaOH) and the apo-protein on ice for 
overnight. The excess hemin was removed by applying to a Sephadex G-25 column 
after the removal of insoluble fraction by centrifugation. 
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2-2-3. Expression and purification of the isolated bHLH-PASA-PASB and 
bHLH-PASA proteins of BMAL1 
Expression and purification of the isolated bHLH-PASA-PASB or bHLH-PASA 
proteins of BMAL1 were carried out basically as described [52]. E. coli 
BL21-CodonPlus (DE3)-RIL cells were transformed with pMAL-c2X containing cDNA 
of BMAL1 bHLH-PASA-PASB or bHLH-PASA. The expression protocol was the same 
as that of His-NPAS2 proteins except the antibiotic was changed from 30 μg/ml 
kanamycin to 50 μg/ml ampicillin. 
The cells expressing each BMAL1 protein were collected by centrifugation and 
the cell extract was prepared by sonication in buffer C (20 mM Tris-HCl, pH 7.4, 200 
mM NaCl, 1 mM EDTA, 2 μg/ml aprotinin, 2 μg/ml leupeptin, 2 μg/ml pepstatin A, 1 
mM PMSF and 2 mM DTT). After ultracentrifugation, the supernatant was applied to an 
Amylose Resin column (New England Biolabs) pre-equilibrated with buffer C. The 
column was washed sequentially with buffer C and buffer C containing 0.01 mM 
maltose. The MBP-tagged proteins were then eluted with buffer C containing 1 mM 
maltose. The protein fractions were applied to a Sephadex G-25 column pre-equilibrated 
with buffer B to remove maltose and for buffer exchange. The purified proteins were 
quickly frozen in liquid nitrogen and stored at -80°C until use. 
 
2-2-4. EMS assay 
The single-stranded oligonucleotides containing a canonical E-box sequence 
(5’-GGGGCGCCACGTGAGAGG-3’ and 5’-GGCCTCTCACGTGGCGCC-3’) were 
annealed and end-labeled with [
32
P] dCTP (Japan Radioisotope Association) by Klenow 
enzyme (Takara) to use as an EMS probe. After the purification by ethanol precipitation, 
32
P-labeled E-box probe was dissolved in TE buffer. 
The DNA-binding reactions were performed for 30 min on ice in 6 μl of the 
reaction mixture (0.3 or 0.6 μM His-NPAS2, 0.6 μM MBP-BMAL1, 0.1 μM 32P-labeled 
E-box, 50 mM HEPES, pH 7.5, 50 mM NaCl, 1.2 mM MgCl2, 10% glycerol, 0.5% 
n-octyl-glycoside, 0.12 mg/ml BSA, 0.05 mg/ml poly-dI-dC (Sigma) and 2 mM DTT). 
To analyze the effects of NAD(P)H on the DNA-binding activity of NPAS2/BMAL1 
heterodimer or BMAL1 homodimer, various concentrations of NAD(P)H were added to 
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the reaction mixture. In competition assays between NAD(P)H and its derivatives, the 
concentration of NAD(P)H was fixed at 2 mM and the derivatives were added to the 
reaction mixture at various concentrations. Because NAD(P)
+
, nicotinic acid and NAAD 
had acidic pH values in aqueous solution, the stock solutions of these compounds were 
pH-adjusted to 7.5 just before the experiments. 
The reaction mixtures were separated by electrophoresis on 5% (w/v) 
non-denaturing acrylamide gels in buffer D (20 mM Tris-acetate and 0.5 mM EDTA) 
for 2.5 h at 100 V and 4°C. After electrophoresis, the gels were dried and analyzed 
using a BAS-1800 II Image Analyzer (Fujifilm) with Multi Gauge V2.1. The binding 
data were analyzed with Igor Pro. 
 
  
- 14 - 
 
2-3. Results and discussion 
 
2-3-1. Protein expression and purification 
The domain structures of truncated proteins of NPAS2 and BMAL1 used in this 
chapter were shown in Figure 2-1. All of the purified proteins were analyzed by 
SDS-PAGE. Purified His-NPAS2 proteins were more than 95% purity, except for 
His-NPAS2 bHLH (1-79 a.a.), which was approximately 60% homogeneity with lower 
yield (Figure 2-2). These results suggest that NPAS2 bHLH (1-61 a.a.) has a more stable 
domain structure than bHLH (1-79 a.a.). Each of the bHLH proteins showed a typical 
α-helical structure in circular dichroism spectra, indicating that it was properly folded 
(Figure 2-3). As shown in Figure 2-4, the UV-vis absorption spectra of the ferric, ferrous 
and ferrous-CO complexes of His-NPAS2 bHLH-PASA were obtained as previously 
reported, confirming the structure of the PASA domain [50]. Purified MBP-BMAL1 
proteins were more than 85% homogeneity as shown in lanes 5 and 6 of Figure 2-2. 
 
 
 
Figure 2-1. Domain structures of truncated NPAS2 and BMAL1 used in this chapter. 
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Figure 2-2. SDS-PAGE analysis of the purified proteins used in this chapter. 
M; Molecular marker, 1; His-NPAS2 bHLH (1-61 a.a.), 
2; His-NPAS2 bHLH (1-79 a.a.), 3; His-NPAS2 bHLH (1-116 a.a.), 
4; His-NPAS2 bHLH-PASA (1-240 a.a.), 5; MBP-BMAL1 bHLH-PASA (74-336 a.a.), 
6; MBP-BMAL1 bHLH-PASA-PASB (1-447 a.a.). 
 
 
 
Figure 2-3. CD spectra of purified His-NPAS2 bHLH-PASA (1-240 a.a.) (A) and 
His-NPAS2 bHLH (1-61 a.a.) (B), in 100 mM Tris-HCl buffer (pH 7.5) containing 10% 
glycerol and 100 mM NaCl.  
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Figure 2-4. The UV-vis absorption spectra of the ferric, ferrous and ferrous-CO 
complexes of His-NPAS2 bHLH-PASA, in 100 mM Tris-HCl buffer (pH 8.0) 
containing 10% glycerol and 1 mM DTT. 
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2-3-2. Effects of NAD(P)H on the DNA-binding activity of truncation mutants of 
NPAS2 
To identify the interaction sites of NPAS2 with NADPH, the effects of NADPH 
on the DNA-binding activity of various truncation mutants of NPAS2 bHLH-PASA 
were examined in an EMS assay. As shown in Figure 2-5, two bands were observed 
when the 
32
P-labeled E-box probe was incubated with both NPAS2 bHLH-PASA and 
BMAL1 bHLH-PASA-PASB proteins in the absence of NADPH. The addition of 5 mM 
NADPH resulted in decrease of the upper band and increase of the lower band. The 
estimated molecular sizes of BMAL1 homodimer and NPAS2/BMAL1 heterodimer are 
186 kDa and 123 kDa, respectively, indicating that the upper and lower bands 
correspond to BMAL1 homodimer and NPAS2/BMAL1 heterodimer. The super-shift 
analysis using an anti-His-tag antibody confirmed that the lower band contained 
His-NPAS2 bHLH-PASA and corresponded to the NPAS2/BMAL1 heterodimer [52]. 
On the other hand, the complex of NPAS2 homodimer with 
32
P-labeled E-box probe 
was not observed under experimental conditions used in this study as previously 
reported [52], although weak binding of holo-NPAS2 to the E-box DNA was observed 
under specific conditions by quartz crystal microbalance analyses [49]. As shown in 
Figure 2-6A, the DNA-binding activity of NPAS2/BMAL1 heterodimer was increased 
by the addition of NADPH in a dose-dependent manner. The EC50 of NADPH for 
NPAS2 bHLH-PASA (1-240 a.a.) was estimated to be 2.3 mM, consistent with the 
results for NPAS2 bHLH-PASA-PASB (1-416 a.a.) in Rutter et al. [51]. NADH also 
enhanced the DNA-binding activity of NPAS2/BMAL1 heterodimer with an EC50 value 
of 3.5 mM (Figure 2-7). 
The His-NPAS2 bHLH truncation mutants were examined under the same 
conditions for NADPH effects. Each mutant of NPAS2 bHLH, NPAS2 bHLH (1-116 
a.a.), bHLH (1-79 a.a.) and bHLH (1-61 a.a.), formed a heterodimer with BMAL1 that 
bound to 
32
P-labeled E-box probe. The addition of NADPH enhanced their 
DNA-binding activities similarly to NPAS2 bHLH-PASA (Figure 2-6B, C and D). The 
EC50 of NADPH for NPAS2 bHLH (1-116 a.a.), bHLH (1-79 a.a.) and bHLH (1-61 a.a.) 
were 3.9, 3.6 and 2.1 mM, respectively. These results indicated that the N-terminal 1-61 
amino acids of NPAS2 were sufficient for heterodimer formation with BMAL1 
bHLH-PASA-PASB, E-box binding and the effect of NADPH. Similar results were 
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obtained with MBP-BMAL1 bHLH-PASA as shown in Figure 2-8. It was surprising 
that NPAS2 bHLH (1-61 a.a.) showed a response to NADPH because this mutant was 
estimated as the minimum size for a bHLH DNA-binding domain from a domain search 
(Figure 2-9). The EC50 value of NPAS2 bHLH (1-61 a.a.) was lower than those of the 
other truncation mutants, suggesting that the fragment could contain an interaction site 
for NADPH. It was also noticed that the addition of NPAS2 bHLH (1-61 a.a.) resulted 
in the drastic decrease of the complex of BMAL1 homodimer with 
32
P-labeled E-box 
probe in the absence of NADPH. Similar results were obtained for NPAS2 bHLH 
(1-116 a.a.) and bHLH (1-79 a.a.), but not for NPAS2 bHLH-PASA (Figure 2-6). These 
results suggest that the heterodimer of NPAS2 bHLH and BMAL1 bHLH-PASA-PASB 
was more likely to be formed than the homodimer of BMAL1, but in the absence of 
NADPH, the affinity of the heterodimer to E-box was not enough to see as a 
retarded-band. Further experiments are needed to elucidate the precise kinetics of the 
NPAS2/BMAL1 heterodimer and BMAL1 homodimer formations and their 
DNA-binding affinities. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-5. A typical autoradiograph of EMS assay-gel. NPAS2 bHLH-PASA (1-240 
a.a.) and BMAL1 bHLH-PASA-PASB (1-447 a.a.) were used in the absence (0) and 
presence (5) of 5 mM NADPH. BB, BMAL1 homodimer with 
32
P-labeled E-box probe; 
NB, NPAS2/BMAL1 heterodimer with the probe. 
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Figure 2-6. Effects of NADPH on the DNA-binding activity of NPAS2 bHLH-PASA 
and bHLH truncated mutants, with BMAL1 bHLH-PASA-PASB. The DNA-binding 
activities of NPAS2 bHLH-PASA (A), bHLH (1-116 a.a.) (B), bHLH (1-79 a.a.) (C) and 
bHLH (1-61 a.a.) (D) were analyzed in the presence of various amounts of NADPH. 
The label “B” at the top of the gel indicates an EMS assay in which BMAL1 protein 
was incubated with DNA in the absence of NPAS2. The DNA-binding activities of 
NPAS2/BMAL1 heterodimer were quantified by Multi Gauge V2.1 and represented 
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relative values normalized to the value obtained in the absence of NADPH. Each dot is 
the mean of at least three independent experiments ± SD. EC50 values were estimated 
from sigmoidal plots fitted to the data.  
 
 
 
 
 
 
 
 
 
 
Figure 2-7. Effects of NADH on the DNA-binding activity of NPAS2 bHLH-PASA 
with BMAL1 bHLH-PASA-PASB. Experimental procedures were described in Figure 
2-6. 
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Figure 2-8. Effects of NADPH on the DNA-binding activity of NPAS2 bHLH-PASA 
(A) and bHLH (1-61 a.a.) (B), with BMAL1 bHLH-PASA. Experimental procedures 
were described in Figure 2-6. 
 
 
 
 
 
Figure 2-9. Sequence alignment of the bHLH domains of NPAS2, CLOCK, and 
BMAL1. The secondary structure elements elucidated from the crystal structure of the 
CLOCK/BMAL1 heterodimer [53, 54] are shaded and marked. 
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2-3-3. Effects of NADPH on the DNA-binding activity of BMAL1 homodimer 
Effects of NADPH on the DNA-binding activity of BMAL1 homodimer were 
examined by EMS assays using the purified bHLH-PASA-PASB and bHLH-PASA 
domains of BMAL1 in the absence of NPAS2. As shown in Figure 2-10, NADPH 
inhibited the DNA-binding activity of BMAL1 homodimer in a dose-dependent manner. 
The DNA-binding activities of BMAL1 bHLH-PASA-PASB and bHLH-PASA were 
50% inhibited by addition of 7.6 and 8.4 mM NADPH, respectively. Interestingly, 
NADPH oppositely affected the DNA-binding activities of NPAS2/BMAL1 
heterodimer and BMAL1 homodimer. The inhibition of the DNA-binding activity of 
BMAL1 homodimer may facilitate NPAS2/BMAL1 heterodimer formation at higher 
concentrations of NADPH. These results indicate that the enhancement of DNA-binding 
activity by NADPH was specific for NPAS2/BMAL1 heterodimer formation and/or the 
interaction between the heterodimer and E-box DNA. These results also suggest that the 
MBP-tag and BMAL1 protein were not sites for activation by NADPH. 
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Figure 2-10. Effects of NADPH on the DNA-binding activity of MBP-BMAL1 
bHLH-PASA-PASB (A) and MBP-BMAL1 bHLH-PASA (B) proteins. The 
DNA-binding activity of BMAL1 homodimer was quantified by Multi Gauge V2.1, and 
the activity represent a relative value normalized to the value obtained in the absence of 
NADPH. Each dot is the mean of at least three independent experiments ± SD. 
 
 
 
  
- 24 - 
 
2-3-4. Effects of NAD(P)H derivatives 
To characterize the interaction between NPAS2 and NAD(P)H more precisely, the 
effects of various NAD(P)H derivatives on the DNA-binding activity of 
NPAS2/BMAL1 heterodimer were examined, and these compounds were also used to 
perform the competition assays with NAD(P)H. The derivatives used in this study were 
shown in Figure 2-11. Rutter et al. reported that NADP
+
 inhibited the DNA-binding 
activity of NPAS2/BMAL1 heterodimer and competed with NADPH at an IC50 of 0.56 
mM [51]. In their system, even addition of equimolar NADP
+
 to a reaction mixture 
containing 2 mM NADPH completely inhibited the formation of the 
NPAS2/BMAL1/DNA complex. Unexpectedly, in the system of present study, NADP
+
 
itself had no effect on the DNA-binding activity of NPAS2/BMAL1 heterodimer 
(Figure 2-12A), and it did not compete with NADPH for the effect, even when the 
5-fold excess of NADP
+
 was added (Figure 2-12B). Similarly, NAD
+
 neither affected 
the DNA-binding activity of NPAS2/BMAL1 heterodimer nor competed with NADH 
(Figure 2-13). The reasons for these inconsistencies are not clear, because the 
experimental conditions for EMS assay in this study are very similar to those described 
by Rutter et al. [51], except that they used the proteins purified from inclusion bodies, 
while proteins used in this study were purified from soluble fraction. 
Other NADPH derivatives, namely 2’,5’-ADP, nicotinamide, nicotinic acid and 
NAAD, were also examined for effects on the DNA-binding activity of NPAS2/BMAL1 
heterodimer. As shown in Figure 2-14A, none of these compounds affected the 
DNA-binding activity of NPAS2/BMAL1 heterodimer when added individually. 
Furthermore, similarly to NADP
+
, they did not either compete with NADPH by addition 
of 5-fold excess to it (Figure 2-14B). Similar results were obtained in competition 
assays using NPAS2 bHLH (1-61 a.a.). In all experiments, the pH values of NADPH 
derivative solutions were adjusted to 7.5 immediately before use, and it was carefully 
confirmed that the pH of the assay solution was not changed by the addition of excess 
derivatives during the assays, because some of them were highly acidic in aqueous 
solution. These results suggest that the reduced form of the nicotinamide moiety was 
critical for the effect of NAD(P)H. All of the reaction mixtures for EMS assays 
contained 2 mM DTT, suggesting that NAD(P)H might not work as a reducing agent 
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but rather that its structure was important for its effects. 
NAD(P)H also enhanced the DNA-binding activity of CLOCK/BMAL1 
heterodimer [51]. Recently, the crystal structures of the bHLH-PASA-PASB domains of 
murine CLOCK/BMAL1 heterodimer [53] and the bHLH domains of human 
CLOCK/BMAL1 heterodimer bound to E-box DNA have been reported [54]. As 
observed in other bHLH proteins, the N-terminal halves of the α1 helices of both 
CLOCK and BMAL1 contain many basic residues to bind DNA, and the C-terminal 
halves of the α1 helices form a four-helix bundle with the α2 helices to stabilize the 
CLOCK/BMAL1 heterodimer. Because the residues in the bHLH domain of CLOCK 
are highly conserved in the bHLH domain of NPAS2, the NPAS2/BMAL1 heterodimer 
is expected to bind to E-box DNA with a similar conformation. It is interesting to note 
that residues 1-61 of NPAS2 are sufficient to form the four-helix bundle of the 
heterodimer (Figure 2-9). Considering the structural requirements for DNA binding and 
heterodimer formation, the binding sites of NAD(P)H on NPAS2 may exist in the loop 
region. Further experiments are required to elucidate the molecular mechanism by 
which NADPH affects the DNA-binding activity of NPAS2/BMAL1 heterodimer or 
BMAL1 homodimer. 
CLOCK is reported to be a histone acetyltransferase (HAT) whose activity is 
counterbalanced by SIRT1, an NAD
+
-dependent histone deacetylase [17, 52]. The 
CLOCK/BMAL1 heterodimer activates transcription of Nampt which encodes a 
rate-limiting enzyme in the NAD
+
 salvage pathway [18]. SIRT1 is recruited with the 
CLOCK/BMAL1 heterodimer and inhibits the transcription of Nampt. Thus, 
intracellular NAD
+
 levels are regulated in a 24-hour cycle in a circadian manner; 
inversely, cell metabolism could regulate CLOCK function. Although NPAS2, unlike 
CLOCK, does not contain any regions with homology to HATs, another HAT, p300, 
exhibits a circadian time-dependent association with NPAS2 [56]. These results suggest 
that both CLOCK and NPAS2 could be regulated by cellular NAD
+
/NADH levels via 
HAT-dependent chromatin remodeling. Therefore, the direct regulation of the 
DNA-binding activities of NPAS2 and CLOCK indicated in this chapter may act as an 
acute system that responds to fluctuations in intracellular NAD(P)H levels. 
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Figure 2-11. Structures of the NAD(P)H derivatives used in this study. 
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Figure 2-12. Effects of NADP
+
 on the DNA-binding activity of NPAS2 bHLH-PASA 
and BMAL1 bHLH-PASA-PASB in the absence (A) or presence (B) of NADPH. The 
DNA-binding activity of NPAS2/BMAL1 heterodimer was not affected by addition of 
NADP
+
 (A). NADP
+
 did not compete with NADPH in the DNA-binding activity of the 
NPAS2/BMAL1 heterodimer (B). The independent experiments were conducted at least 
three times, and DNA-binding activity relative to that obtained without NADP
+
 and 
NADPH is shown as the mean ± SD (n = 3). 
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Figure 2-13. Effects of NAD
+
 on the DNA-binding activity of NPAS2 bHLH-PASA and 
BMAL1 bHLH-PASA-PASB in the absence (A) or presence (B) of NADH. The 
DNA-binding activity of NPAS2/BMAL1 heterodimer was not affected by addition of 
NAD
+
 (A). NAD
+
 did not compete with NADH in the DNA-binding activity of the 
NPAS2/BMAL1 heterodimer (B). The independent experiments were conducted at least 
three times, and DNA-binding activity relative to that obtained without NAD
+
 and 
NADH is shown as the mean ± SD (n = 3). 
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Figure 2-14. Effects of NAD(P)H derivatives on the DNA-binding activity of NPAS2 
bHLH-PASA/BMAL1 bHLH-PASA-PASB heterodimer. Only NADPH had an effect; 
NADP
+
, NAD
+, 2’,5’-ADP, nicotinamide, nicotinic acid, and NAAD had no effect on 
the DNA-binding activity of NPAS2/BMAL1 heterodimer. All derivatives were 
examined at 10 mM (A). Competition assays with NAD(P)H derivatives in the presence 
of 2 mM NADPH. 10 mM of derivatives were added to the reaction mixture; other 
conditions are described in Materials and Methods (B). 
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Chapter 3. 
pH and NAD(P)H additively regulate the DNA-binding 
activity of NPAS2 
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3-1. Introduction 
 
In mammals, physiological and behavioral rhythms are controlled by the circadian 
molecular clock system [2-4]. The central clock, which exists in the hypothalamic 
suprachiasmatic nucleus (SCN), is entrained mainly by cycles of light and darkness, 
whereas the peripheral clocks in various tissues are synchronized by the central clock. 
At the molecular level, the circadian clock consists of transcriptional and translational 
feedback loops of clock genes and proteins [2-4].  
Neuronal PAS domain protein 2 (NPAS2), a homolog of CLOCK, is a core 
transcription factor for mammalian circadian clock. Similar to CLOCK, NPAS2 forms a 
heterodimer with BMAL1, which binds to E-box or E-box-like elements in the 
regulatory regions of numerous clock genes and clock controlled genes to activate the 
expression of these genes [6, 32, 35]. NPAS2 consists of a bHLH domain, two PAS 
domains (PASA and PASB) and a transactivation domain. The bHLH domain of NPAS2 
serves as a basic DNA-binding domain and a dimerization domain with other bHLH 
proteins. It was reported that the DNA-binding activity of the NPAS2/BMAL1 
heterodimer was enhanced by NADH and NADPH [51]. Further, as described in the 
chapter 2, the bHLH domain of NPAS2 containing the N-terminal 1-61 amino acids was 
revealed to be sufficient to form a heterodimer with BMAL1, to bind to E-box and to 
sense NAD(P)H. The PAS domains of NPAS2, on the other hand, serve as 
protein-protein interaction sites for dimerization and heme-containing gas sensor 
domains [47, 48]. Although the two PAS domains bind heme, the main gas sensor is the 
PASA domain because the CO binding affinity of PASB-heme is less than 10% of that 
of PASA-heme [47]. The binding of CO to the heme of the PASA domain inhibits the 
DNA-binding activity of the NPAS2/BMAL1 heterodimer. During these studies, it was 
also found that the complex formation of the NPAS2/BMAL1 heterodimer with DNA 
was affected by pH. 
Recently, two research groups reported that extracellular pH levels affected the 
expression rhythms of clock genes in cultured cells, indicating that pH could be a cue 
for the molecular clock [57, 58]. However, little is known about the molecular 
mechanism of the regulation of circadian rhythm by pH. Nonetheless, it is known that 
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pH plays a critical role in many cellular functions, such as the cell cycle, proliferation, 
metabolism, the synthesis of cellular macromolecules and signal transduction [59]. 
Therefore, the intracellular pH of mammalian cells is strictly maintained within a 
narrow range, even though it varies among different organelles. For example, the 
cytoplasmic and nuclear pH values are regulated at approximately 7.2, while those of 
mitochondria and lysosomes are approximately 8 and 4.7, respectively [60]. 
Additionally, the extracellular fluid has various pH values depending on the tissue and 
organ: the pH of plasma is slightly alkaline (7.3-7.4), while the digestive organs have a 
very low pH. Furthermore, extracellular acidification has been observed to be as low as 
pH 6.5 in tumor tissues in comparison to normal tissues [61]. In this chapter, therefore, 
the effects of pH on the DNA-binding activity of NPAS2 in vitro and NPAS2-dependent 
transcriptional activity in mammalian cells were examined. The additive effects of 
NADPH on the DNA-binding activity of NPAS2 were further elucidated under various 
pH conditions. 
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3-2. Materials and methods 
 
3-2-1. Plasmid constructions 
The expression plasmids for EMS assay, NPAS2 bHLH-PASA/pET-28a(+), 
NPAS2 bHLH/pET-28a(+) and BMAL1 bHLH-PASA-PASB/pMAL-c2X were 
described in the chapter 2-2-1. To create the expression plasmid for a truncation mutant 
of BMAL1, BMAL1 bHLH (74-128 a.a.), PCR was performed using pMAL-c2X 
containing BMAL1 bHLH-PASA-PASB cDNA as the template. The primers used for 
the PCR were 5’-GGGATCCCATATGAGGGAGGCCCACAGTC-3’ as the sense 
primer and 5’-CGAATTCGTCGACTAGGCACCTCTCAAAG-3’ as the antisense 
primer. The resulting product was subcloned into the Nde I and Sal I sites of pET-28a(+). 
The expression plasmid for His-tagged murine CLOCK bHLH-PASA (10-265 a.a.) was 
previously constructed [62]. The corresponding cDNA was cloned into the Nde I and 
Sal I sites of pET-28a(+). To create the expression plasmid for a truncation mutant of 
CLOCK, CLOCK bHLH (10-86 a.a.), PCR was performed using pET-28a(+) containing 
CLOCK bHLH-PASA (10-265 a.a.) cDNA as the template. The primers used for PCR 
were 5’-CGGGATCCCATATGAGCTCAATTG-3’ as a sense primer and 
5’-CCCGTCGACCTACTCTTTATGTTTGCGC-3’ as antisense primer. The resulting 
product was subcloned into the Nde I and Sal I sites of pET-28a(+). All of the desired 
constructs were confirmed by sequencing. 
The plasmids for a luciferase assay, Npas2/pCGN and Bmal1/pcDNA for 
expressing full-length murine NPAS2 (1-816 a.a.) and murine BMAL1 (1-626 a.a.), 
respectively, were previously constructed [52]. The corresponding cDNA of NPAS2 was 
cloned into the Xba I and Hind III sites of pCGN, and that of BMAL1 was cloned into 
the BamH I and EcoR I sites of pcDNA. A reporter plasmid, mPer1p/pSLO, containing 
the murine Per1 enhancer/promoter region (-1803 to +40) that has three canonical 
E-boxes (CACGTG) was also constructed previously by subcloning the region into the 
Nhe I and Bgl II sites of the pSLO-test vector [52]. Another reporter plasmid, 
mPer1p-E3M/pSLO was prepared by PCR-based method for mutation. In this reporter 
plasmid, all of the three E-boxes in mPer1 enhancer/promoter region were mutated to 
TCTAGA. The desired mutations were confirmed by sequencing. 
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3-2-2. Expression and purification of truncated NPAS2, BMAL1 and CLOCK 
proteins 
Expression and purification of the isolated bHLH-PASA (1-240 a.a.) or bHLH 
(1-61 a.a.) proteins of NPAS2 and the isolated bHLH-PASA-PASB (1-447 a.a.) protein 
of BMAL1 were carried out as described in the chapter 2-2-2 and 2-2-3, respectively,  
except that E. coli BL21-CodonPlus (DE3)-RIPL (Stratagene) was used as the host cell.  
The His-tagged bHLH domain of BMAL1, BMAL1 bHLH (74-128 a.a.), was 
expressed in E. coli BL21-CodonPlus (DE3)-RIPL cells and purified similarly to 
His-NPAS2 bHLH. The purified protein was applied to a Sephadex G-25 column 
pre-equilibrated with buffer B to exchange the buffer to the appropriate one. 
Expression of the isolated bHLH-PASA domains of CLOCK was performed using 
the plasmid CLOCK bHLH-PASA (10-265 a.a.)/pET-28a(+) with coexpression of E. 
coli chaperones, GroES and GroEL (the plasmid pGroESL was a gift from DuPont de 
Nemours and Co.), in BL21 (DE3) (Stratagene) cells. The cells were cultured and 
treated with 0.05 mM IPTG similarly to that of His-NPAS2 bHLH-PASA. The cell 
extract was prepared by sonication in buffer E (50 mM sodium phosphate, pH 7.8, 100 
mM NaCl, 10% glycerol, 2 μg/ml aprotinin, 2 μg/ml leupeptin, 2 μg/ml pepstatin A, 1 
mM PMSF, 0.2 mM DTT). After ultracentrifugation, the supernatant was adjusted to 
50% saturated ammonium sulfate, incubated at 4 °C for 1 h and centrifuged again. The 
precipitate was dissolved in buffer E and applied to a Sephadex G-25 column 
pre-equilibrated with buffer E to remove ammonium sulfate. The resulting solution was 
applied to a Ni-NTA agarose column pre-equilibrated with buffer E and the column was 
sequentially washed with buffer E containing 50 mM and 80 mM imidazole. 
His-CLOCK bHLH-PASA was then eluted with buffer E containing 250 mM imidazole. 
The protein was applied to a Sephadex G-25 column pre-equilibrated with buffer B to 
remove the imidazole. His-CLOCK bHLH-PASA was prepared as holo-protein by 
reconstitution with hemin and apo-protein, similarly to His-NPAS2 bHLH-PASA. 
Expression and purification of the isolated bHLH domain of CLOCK, CLOCK 
bHLH (10-86 a.a.), was carried out similarly to NPAS2 bHLH. The purified protein was 
applied to a Sephadex G-25 column to exchange the buffer with buffer B. 
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3-3-3. EMS assay 
The 
32
P-labeled E-box probe was prepared as described in the chapter 2-2-4 and 
purified with a gel-filtration column instead of ethanol precipitation. The concentration 
of labeled probe was determined in a competition analysis of the DNA-binding activity 
with unlabeled E-box probe whose concentration was spectrophotometrically estimated 
and confirmed on a 15% polyacrylamide gel by comparison with a double-strand DNA 
standard. 
The DNA-binding reactions were typically performed as described in the chapter 
2-2-4 in the presence or absence of 5 mM NADPH (Oriental yeast). To analyze the 
effects of pH on the DNA-binding activity of NPAS2/BMAL1 or CLOCK/BMAL1 
heterodimer or BMAL1 homodimer, the pH of the reaction mixtures were varied from 
pH 6.5 to pH 8.5. In assays for the DNA-binding rate and affinity of the 
NPAS2/BMAL1 heterodimer or BMAL1 homodimer, the concentrations of proteins or 
DNA probe in the mixtures and the reaction time were variously altered for analysis, as 
described in detail in each figure legend. 
The reaction mixtures were separated by electrophoresis on 5% or 7.5% (w/v) 
native acrylamide gels in buffer D for 2 h at 100 V and 4 °C. After electrophoresis, the 
gels were dried and analyzed as described in the chapter 2-2-4. 
 
3-3-4. Cell culture and luciferase assay 
NIH3T3 cells were seeded in 24-well plates (2 × 10
4
 cells per well) (Iwaki) with 
DMEM (code no. 08456, Nacalai) containing 5% FBS (Equitech-bio) and cultured for 
16 h at 37 °C under 5% CO2 prior to transfection. The NPAS2 expression plasmid 
Npas2/pCGN (0.01 μg), the BMAL1 expression plasmid Bmal1/pcDNA (0.025 μg), a 
reporter plasmid, mPer1p/pSLO or mPer1p-E3M/pSLO (0.2 μg), and an internal 
control plasmid, pSLG-SV40 (0.025 μg) (Toyobo), were cotransfected into cells using 
Trans
TM
 First Reagent (Promega). The total amount of DNA was brought to 0.3 μg by 
the addition of the empty vector. After a 3-h treatment with the transfection mixture at 
5% CO2 and 37 °C, the medium was replaced with DMEM/5% FBS at pH 6.8, 7.2 or 
7.7. Before use, the pH of the medium preincubated for 2 h at 37 °C and 5% CO2 was 
adjusted and the medium was further incubated for 1 h at 37 °C and 5% CO2; there was 
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little change in the pH of each medium (pH 6.8, 7.2 and 7.7, respectively) after another 
24 h of cell culturing. The medium was then removed and the cells were lysed to 
analyze luciferase activities using MultiReporter Assay System-Tripluc
TM
-Detection 
Reagents (Toyobo) according to the manufacturer’s protocols. The relative luciferase 
activities were normalized to the activity obtained from the internal control, 
pSLG-SV40. 
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3-3. Results 
 
3-3-1. DNA-binding activities of NPAS2 at various pH values in vitro 
Several truncated proteins of NPAS2, BMAL1 and CLOCK were overexpressed 
and purified to examine the effects of pH on their DNA-binding activities. The domain 
structures of proteins used in this chapter are shown in Figure 3-1. All of the purified 
proteins were analyzed by SDS-PAGE, which showed more than 90% homogeneity 
(Figure 3-2). The UV-vis absorption spectra of the ferric, ferrous and CO-bound forms 
of His-NPAS2 bHLH-PASA and His-CLOCK bHLH-PASA were obtained as previously 
reported, confirming the structures of the PASA-domains [50]. 
 
 
 
 
Figure 3-1. Domain structures of truncated NPAS2 (A), BMAL1 (B) and CLOCK (C) 
mutants used in this chapter. 
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Figure 3-2. SDS-PAGE analyses of purified NPAS2 (A), BMAL1 (B), and CLOCK (C) 
mutants used in this chapter. 
M; Molecular marker, 1; His-NPAS2 bHLH-PASA (1-240 a.a.), 
2; NPAS2 bHLH (1-61 a.a.), 3; MBP-BMAL1 bHLH-PASA-PASB (1-447 a.a.),   
4; BMAL1 bHLH (74-128 a.a.), 5; His-CLOCK bHLH-PASA (10-265 a.a.), 
6; His-CLOCK bHLH (10-86 a.a.). 
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The DNA-binding activity of His-NPAS2 bHLH-PASA was examined at various 
pH values by an EMS assay. As shown in Figure 3-3A and 3-3B, the DNA-binding 
activity of the NPAS2/BMAL1 heterodimer increased with pH. Indeed, the activity at 
pH 8.5 was approximately 2.0- and 4.1-fold higher than that at pH 7.5 and pH 6.5, 
respectively, in the absence of NADPH. The addition of NADPH further increased the 
DNA-binding activity at each pH value. The DNA-binding activity increased up to 
2.7-fold at pH 7.5 and 3.2-fold at pH 6.5 in the presence of NADPH (Figure 3-3B). 
These results indicate that the effects of pH and NADPH were additive in enhancing 
NPAS2/BMAL1/DNA complex formation. As described in the chapter 2-3-2, the 
N-terminal 61 amino acids of NPAS2, NPAS2 bHLH (1-61 a.a.), were sufficient to form 
a heterodimer with BMAL1, bind to the E-box and sense NADPH. Effects of pH on 
NPAS2 bHLH (1-61 a.a.) were also examined after the elimination of the His-tag by 
thrombin (Figure 3-3C). Similar to His-NPAS2 bHLH-PASA, the DNA-binding activity 
of NPAS2 bHLH was increased by pH and NADPH, indicating that the N-terminal 1-61 
amino acids of NPAS2 were sufficient to sense pH and that these effects were 
independent of the His-tag (Figure 3-3C). Moreover, the DNA-binding activity of 
His-NPAS2 bHLH-PASA (1-240 a.a.) with BMAL1 bHLH (74-128 a.a.) without tag 
was also affected by pH, as with MBP-BMAL1 bHLH-PASA-PASB, indicating that the 
PASA and PASB domains of BMAL1 and MBP-tag were not responsible for the 
observed effects of pH alteration (Figure 3-4). The similar effects of pH and NADPH on 
the complex formation of the CLOCK/BMAL1 heterodimer with E-box DNA were 
observed, as shown in Figure 3-5. In the case of CLOCK, the bHLH domain containing 
10-86 amino acids was essential and sufficient to sense pH and NADPH, similar to 
NPAS2. 
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Figure 3-3. Effects of pH on the DNA-binding activity of NPAS2 bHLH-PASA (1-240 
a.a.) and NPAS2 bHLH (1-61 a.a.). EMS assay using His-NPAS2 bHLH-PASA (1-240 
a.a.) and MBP-BMAL1 bHLH-PASA-PASB at various pH values in the absence or 
presence of 5 mM NADPH. The label “B” at the top of the gel indicates an EMS assay 
in which the BMAL1 protein was incubated with DNA in the absence of NPAS2. BB, 
BMAL1/BMAL1 homodimer with 
32
P-labeled E-box probe; NB, NPAS2/BMAL1 
heterodimer with 
32
P-labeled E-box probe (A). The relative DNA-binding activity of 
NPAS2/BMAL1 heterodimer at various pH in the absence (white) or presence (gray) of 
NADPH. The intensity of the bands shown in (A) was quantified by Multi Gauge V2.1 
and represented as a relative value normalized to the value obtained at pH 7.5 in the 
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absence of NADPH. Each value is the mean of at least three independent experiments ± 
SD (B). The relative DNA-binding activity of His-NPAS2 bHLH (1-61 a.a.) with 
MBP-BMAL1 bHLH-PASA-PASB at various pH values in the absence or presence of 5 
mM NADPH. The conditions for the EMS assay were the same as for (A), as described 
in “Experimental Procedures”. Each value is the mean of at least three independent 
experiments ± SD (C). 
 
 
 
 
 
 
 
Figure 3-4. Effects of pH on the DNA-binding activity of His-NPAS2 bHLH-PASA 
(1-240 a.a.) and BMAL1 bHLH (74-128 a.a.) without tag. The EMS assay using 
His-NPAS2 bHLH-PASA and BMAL1 bHLH at various pH in the absence or presence 
of 5 mM NADPH. The label “B” at the top of the gel indicates an EMS assay in which 
BMAL1 protein was incubated with DNA in the absence of NPAS2. BB, 
BMAL1/BMAL1 homodimer with 
32
P-labeled E-box probe; NB, NPAS2/BMAL1 
heterodimer with 
32
P-labeled E-box probe (A). The intensity of the bands shown in (A) 
was quantified by Multi Gauge V2.1 and represented as a relative value normalized to 
the value obtained at pH 7.5 in the absence of NADPH. Each value is the mean of at 
least three independent experiments ± SD (B). 
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Figure 3-5. Effects of pH on the DNA-binding activity of His-CLOCK and 
MBP-BMAL1. The EMS assay using His-CLOCK bHLH-PASA (10-265 a.a.) (A) or 
His-CLOCK bHLH (10-86 a.a.) (B) and MBP-BMAL1 bHLH-PASA-PASB at various 
pH in the absence or presence of 5 mM NADPH. The label “B” at the top of the gel 
indicates an EMS assay in which BMAL1 protein was incubated with DNA in the 
absence of CLOCK. BB, BMAL1/BMAL1 homodimer with 
32
P-labeled E-box probe; 
CB, CLOCK/BMAL1 heterodimer with 
32
P-labeled E-box probe. The right panels 
indicate the relative DNA-binding activity of CLOCK/BMAL1 heterodimer at various 
pH in the absence (white) or presence (gray) of NADPH. The intensity of the bands was 
quantified by Multi Gauge V2.1 and represented as a relative value normalized to the 
value obtained at pH 7.5 in the absence of NADPH. Each value is the mean of at least 
three independent experiments ± SD. 
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3-3-2. DNA-binding activity of BMAL1 at various pH values 
Since the DNA-binding activity of NPAS2/BMAL1 heterodimer was affected by 
pH, the effects of pH on the DNA-binding activity of BMAL1 homodimer was 
examined by an EMS assay in the absence of NPAS2. As shown in Figure 3-6, the 
DNA-binding activity of MBP-BMAL1 bHLH-PASA-PASB homodimer was not 
significantly affected by pH in the absence or presence of NADPH, though the addition 
of 5 mM NADPH rather inhibited the activity, as described in the chapter 2-3-3. These 
results indicate that NPAS2, but not BMAL1, is responsible for the regulation of the 
DNA-binding activity of NPAS2/BMAL1 heterodimer by pH. Therefore, further studies 
focused on the effects of pH and NADPH on the affinity of E-box DNA to 
NPAS2/BMAL1 heterodimer. 
 
 
 
Figure 3-6. The DNA-binding activity of BMAL1 at various pH values in the absence 
of NPAS2. EMS assay using MBP-BMAL1 bHLH-PASA-PASB at various pH values in 
the absence or presence of NADPH (A). The DNA-binding activity of BMAL1/BMAL1 
homodimer in the absence (white) or presence (gray) of NADPH. The intensity of the 
bands shown in (A) was quantified and represented as a relative value normalized to the 
value obtained at pH 7.5 in the absence of NADPH. Each value is the mean of at least 
three independent experiments ± SD (B).  
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3-3-3. Kinetics of DNA-binding of BMAL1 homodimer and NPAS2/BMAL1 
heterodimer 
To further elucidate the effects of pH and NADPH on the DNA-binding of the 
NPAS2/BMAL1 heterodimer, their kinetics were analyzed by an EMS assay with 
several modifications of the standard protocol, as described in the chapter 3-3-3. 
Initially, the DNA-binding rete of MBP-BMAL1 bHLH-PASA-PASB homodimer was 
examined at pH 7.5 in the absence of NPAS2. As shown in Figure 3-7, the 
DNA-binding activity of BMAL1 homodimer reached a plateau within 10 min in a 
reaction mixture containing 20 nM of BMAL1 as the monomer concentration and 50 
nM of E-box DNA. Figure 3-8 shows the binding affinity of E-box DNA to BMAL1 
homodimer, with an apparent dissociation constant (KD
app
) of 17 nM. 
 
 
 
 
 
Figure 3-7. Time course of BMAL1 homodimer complex formation with DNA at pH 
7.5 in EMS assay. The reaction mixture contained 20 nM MBP-BMAL1 
bHLH-PASA-PASB and 50 nM E-box DNA (10 nM of 
32
P-labeled and 40 nM of cold) 
in the absence of NPAS2, and was incubated on ice. The activity is represented as a 
relative value of BMAL/BMAL1 homodimer complex with DNA quantified by Multi 
Gauge V2.1. 
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Figure 3-8. The effects of E-box DNA concentration on the complex formation of 
MBP-BMAL1 bHLH-PASA-PASB homodimer with DNA in EMS assay. The reaction 
mixtures contained 20 nM MBP-BMAL1 bHLH-PASA-PASB and various amount of 
E-box DNA, as indicated; incubation was for 30 min on ice. The activity is represented 
as a relative value of BMAL/BMAL1 homodimer complex with DNA quantified by 
Multi Gauge V2.1. Each value is the mean of at least three independent experiments ± 
SD. 
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After 20-min incubation for the equilibration between E-box DNA (50 nM) and 
BMAL1 (20 nM monomer), an excess amount of His-NPAS2 bHLH-PASA (400 nM) 
was added to the reaction mixture to examine the complex formation between 
NPAS2/BMAL1 heterodimer and E-box DNA. As shown in Figure 3-9, the dissociation 
of BMAL1 homodimer from E-box DNA was completed within 5 min and was 
immediately followed by the binding of NPAS2/BMAL1 heterodimer to E-box DNA in 
the absence of NADPH. The addition of NADPH to the system accelerated the 
dissociation of BMAL1 homodimer from E-box and the binding of NPAS2/BMAL1 
heterodimer to E-box. It is noteworthy that the maximum amount of 
NPAS2/BMAL1/DNA complex was 0.6-fold of that of BMAL1/BMAL1/DNA complex 
in the absence of NADPH, demonstrating that the affinity of DNA to NPAS2/BMAL1 
heterodimer was lower than that to BMAL1 homodimer under these conditions, 
consistent with the KD
app
 values for NPAS2/BMAL1 heterodimer described below. In 
addition, the maximum amount of NPAS2/BMAL1/DNA complex was 3.7-fold that of 
BMAL1/BMAL1/DNA complex in the presence of NADPH, indicating that NADPH 
significantly increased NPAS2/BMAL1/DNA complex formation. 
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Figure 3-9. Time course of complex formation of NPAS2/BMAL1 heterodimer and 
decrease in BMAL1 homodimer complex with DNA at pH 7.5 in the absence (A) or 
presence (B) of NADPH in EMS assay. The reaction mixtures contained 50 nM E-box 
DNA, 20 nM MBP-BMAL1 bHLH-PASA-PASB and 400 nM of His-NPAS2 
bHLH-PASA. After 20 min incubation on ice without NPAS2, NPAS2 was added to the 
reaction mixture and incubated on ice. The complexes with DNA were quantified by 
Multi Gauge V2.1 and represented as a relative value normalized to the value of the 
BMAL1 homodimer complex with DNA in the absence of NPAS2 and NADPH. 
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Next, the effects of the amount of NPAS2 relative to that of BMAL1 on the 
formation of the NPAS2/BMAL1/DNA complex were examined (Figure 3-10). 
Formation of the NPAS2/BMAL1/DNA complex was increased with an increasing 
concentration of NPAS2 in the reaction mixture, whereas formation of the 
BMAL1/BMAL1/DNA complex was decreased to an undetectable level in the EMS 
assay. In the absence of NADPH, the maximum DNA-binding activity of 
NPAS2/BMAL1 heterodimer was again lower than that of BMAL1 homodimer, even 
though the free probe was still abundant (more than 90% of the total amount) in the 
reaction mixture (Figure 3-10A). The addition of 5 mM NADPH resulted in great 
increase in NPAS2/BMAL1/DNA complex formation (Figure 3-10B). The amount of 
DNA used for both NPAS2/BMAL1/DNA and BMAL1/BMAL1/DNA complex 
formation was maximum 5% and 10% of the total amount in the absence and presence 
of NADPH, respectively, indicating that enough amount of free DNA still remained in 
the reaction mixture. These results also indicated that about 25% of BMAL1 protein 
was bound to the E-box DNA in the absence of NADPH. BMAL1 exists in equilibrium 
between BMAL1 dimer and oligomers in solution as shown in the results of 
gel-filtration (Figure 3-11), and the addition of DNA, NPAS2, and/or NADPH changes 
the equilibrium. In the presence of NADPH, the maximum amount of 
NPAS2/BMAL1/DNA increased to 2.7-fold of that of BMAL1/BMAL1/DNA (Figure 
3-10B), indicating that more BMAL1 than that contained in BMAL1/BMAL1/DNA 
complex could form a heterodimer with NPAS2 and bound to DNA under conditions of 
the present study. A similar experiment was also performed at pH 7.0 (Figure 3-12). 
Although the shift in pH of the reaction mixture from pH 7.5 to pH 7.0 resulted in a 
decrease in the DNA-binding activity of NPAS2/BMAL1 heterodimer, NADPH again 
increased the formation of NPAS2/BMAL1/DNA complex. Taken together, these results 
demonstrated that 400 nM of NPAS2, which was 20-fold excess compared to BMAL1 
(20 nM), was sufficient to saturate the formation of the NPAS2/BMAL1/DNA complex, 
with a background level of BMAL1/BMAL1/DNA complex formation. 
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Figure 3-10. Effects of NPAS2 concentration on the complex formation of 
NPAS2/BMAL1 heterodimer with DNA. The reaction mixtures contained 50 nM E-box 
DNA, 20 nM MBP-BMAL1 bHLH-PASA-PASB and various concentrations of 
His-NPAS2 bHLH-PASA (0, 5, 10, 20, 40, 60, 100 and 400 nM) (A). The complexes 
with DNA in (A) were quantified by Multi Gauge V2.1 in the absence or presence of 5 
mM NADPH and represented as a relative value normalized to the value of the BMAL1 
homodimer complex with DNA in the absence of NPAS2 and NADPH (B). 
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Figure 3-11. Gel filtration analysis of NPAS2/BMAL1/E-box complex. Elution profiles 
of NPAS2/BMAL1/E-box mixture. NPAS2 bHLH-PASA, BMAL1 bHLH-PASA-PASB 
and E-box (3 µM each) were incubated for 30 min in the absence (dashed line) or 
presence (solid line) of 10 mM NADPH on ice before the chromatography. The proteins, 
DNA, or NADPH were assigned to each peak based on the molecular weights estimated 
from the calibration curve obtained by using standard proteins (ferritin, BSA, OVA, 
myoglobin and RNase A). The peak(s) for NPAS2 bHLH-PASA was not detectable for 
the very low absorbance at 280 nm. column, COSMOSIL 5Diol-300-II; buffer, 100 mM 
Tris-HCl (pH 7.5), 10% glycerol, and 1 mM DTT; flow rate, 1 ml/min; temperature, r. t. 
(A). SDS-PAGE of the fraction eluted at around 15 ml from the gel-filtration column in 
the presence of NADPH with silver staining. The results confirmed that the fraction 
contained NPAS2 bHLH-PASA and BMAL1 bHLH-PASA-PASB (B). 
 
 
  
(A) 
(B) 
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Figure 3-12. Effects of NPAS2 concentration on the complex formation of 
NPAS2/BMAL1 heterodimer with DNA at pH 7.0. Experimental procedures were 
described in Figure 3-10. 
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3-3-4. Effects of pH and NADPH on the DNA-binding affinity of NPAS2 
To evaluate the effects of pH and NADPH on the DNA-binding activity of NPAS2 
quantitatively, the apparent dissociation constant (KD
app
) of E-box DNA to the 
NPAS2/BMAL1 heterodimer was determined by EMS assay in a reaction mixture 
containing 400 nM of NPAS2 bHLH-PASA and 20 nM of BMAL1 bHLH-PASA-PASB 
with various concentrations of E-box DNA in the absence or presence of NADPH. High 
concentrations of E-box DNA were achieved by the addition of cold E-box DNA to the 
labeled probe. As expected, only bands corresponding to NPAS2/BMAL1 heterodimer 
were detected under these conditions (Figure 3-13A). The signals for the 
NPAS2/BMAL1/DNA complex were quantified and corrected to draw fitting curves 
(Figure 3-13B). At pH 7.5, the KD
app
 values determined from the fitting curves were 45 
and 14 nM in the absence and presence of NADPH, respectively. Similarly, the KD
app
 
values of the E-box DNA to NPAS2/BMAL1 heterodimer were determined at various 
pH conditions in the absence (Figure 3-14A) or presence of NADPH (Figure 3-14B), as 
summarized in Table 3-1. In the absence of NADPH, a pH change from 6.5 to 8.0 
resulted in a decrease in the KD
app
 value from 125 to 22 nM, with an 8-fold increase in 
the maximum level of DNA-binding of NPAS2/BMAL1 heterodimer (Bmax). The KD
app
 
value was also decreased from 125 to 21 nM by the addition of NADPH at pH 6.5. In 
both the absence and presence of NADPH, the DNA-binding affinity of the 
NPAS2/BMAL1 heterodimer increased with pH, and it was further increased by the 
addition of NADPH, indicating that the effects of pH and NADPH were additive. 
Furthermore, the DNA-binding activity of NPAS2/BMAL1 heterodimer was more 
sensitive to pH in the absence of NADPH. 
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Figure 3-13. Effects of pH and NADPH on the DNA-binding affinity of 
NPAS2/BMAL1 heterodimer. EMS assays were performed with various amount of 
DNA at pH 7.5. The reaction mixtures contained 20 nM MBP-BMAL1 
bHLH-PASA-PASB, 400 nM His-NPAS2 bHLH-PASA and various concentrations of 
E-box DNA (total 0, 5, 10, 15, 20, 40, 60, 80 and 100 nM of DNA in the absence of 
NADPH, or total 0, 5, 10, 15, 20, 25, 30, 40 and 50 nM of DNA in the presence of 5 
mM NADPH). Each DNA contained 5 nM of 
32
P-labeled probe (A). The DNA-binding 
activity of the NPAS2/BMAL1 heterodimer at pH 7.5 shown in (A) was quantified and 
represented as a relative value normalized to the maximum value obtained from the 
fitting curve in the absence of NADPH. Each dot is the mean of at least three 
independent experiments ± SD. The KD
app
 values were estimated from a sigmoidal plot 
fitted to the data. 
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Figure 3-14. The DNA-binding affinity of NPAS2/BMAL1 heterodimer at various pH 
in the absence (A) or presence (B) of NADPH. All obtained data were analyzed as 
described for Figure 3-13. Each dot is the mean of at least three independent 
experiments ± SD. The KD
app
 values estimated from a sigmoidal plot fitted to the data 
are summarized in Table 3-1. 
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Table 3-1. Effects of pH and NADPH on the KD
app
 value of E-box DNA to the 
NPAS2/BMAL1 heterodimer and the maximum value of relative binding activity (Bmax). 
      
   0 mM NADPH  
     pH   6.5  7.0  7.5  8.0  
 KD
app
 (nM)   125  61  45  22 
 Bmax  0.18 0.29 1.00 1.44  
      
   5 mM NADPH  
     pH   6.5  7.0  7.5  8.0  
 KD
app
 (nM) 21  18  14 9 
 Bmax  1.08 1.32 1.71 1.81  
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3-3-5. Effects of pH on the transcriptional activity of NPAS2 in cells 
A luciferase assay in mouse NIH3T3 cells was carried out to investigate whether 
the transcriptional activity of NPAS2 was affected by extracellular pH. Two reporter 
plasmids, mPer1p/pSLO containing the enhancer/promoter region of mouse Per1 
(-1803 to +40) harboring three canonical E-boxes (CACGTG) and mPer1p-E3M/pSLO 
containing three-mutated E-boxes (M; TCTAGA) instead of canonical E-boxes in 
mPer1 enhancer/promoter region, were used for assays (Figure 3-15A). The luciferase 
activities for both mPer1p/pSLO and mPer1p-E3M/pSLO without transfection of the 
NPAS2 expression plasmid did not change very much with increasing pH (6.8, 7.2 and 
7.7). By the transfection of the full-length NPAS2 expression plasmid, the activities for 
mPer1p/pSLO significantly increased, whereas the activities for mPer1p-E3M/pSLO 
were not much affected (Figure 3-15B). The NPAS2-dependent transcriptional activity 
at each pH was evaluated by subtracting the activity without NPAS2 expression from 
that with NPAS2 expression. As shown in Figure 3-15C, the NPAS2-dependent 
transcriptional activity for mPer1p/pSLO increased with pH, whereas that for 
mPer1p-E3M/pSLO rather decreased. These results suggested that the extracellular pH 
affected the expression of the mPer1 gene via E-box/NPAS2 in cells. 
 
  
- 57 - 
 
 
 
Figure 3-15. Effects of pH on the transcriptional activity of full-length NPAS2 in 
NIH3T3 cells. Construction of mPer1p and mPer1p-E3M reporter was illustrated. The 
mPer1 promoter region contains three canonical E-boxes (CACGTG). In mPer1p-E3M 
reporter plasmid, all of the three E-boxes were mutated to TCTAGA (A). Relative 
luciferase activity for mPer1p (E) and mPer1p-E3M (M) reporter plasmids in cells 
cultured at pH 6.8, pH 7.2 and pH 7.7 for 24 h in the absence (-) or presence (+) of the 
NPAS2 expression plasmid, Npas2/pCGN. Luciferase activity is represented as a 
relative value to that obtained with mPer1p reporter and Npas2 empty vector, pCGN, at 
pH 6.8. Each value is the mean of at least three independent experiments ± SD. 
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Significant differences between a and b were evaluated by the t test (p <0.02) (B). 
NPAS2-dependent transcriptional activity via E-boxes increased with pH. The 
NPAS2-dependent luciferase activities for mPer1p (E) and mPer1p-E3M (M) reporter 
plasmids were calculated by subtracting the activities without Npas2 from the activities 
with Npas2 at each pH, as shown in (B) (C). 
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3-4. Discussion 
 
In this chapter, using the EMS assay, it was showed that the DNA-binding activity 
of NPAS2/BMAL1 heterodimer increased with increasing pH. The addition of NADPH 
to the system further increased the complex formation of NPAS2/BMAL1 heterodimer 
with E-box DNA at each pH value, indicating that the observed pH and NADPH effects 
were additive (Figure 3-3). As described in the chapter 2-3-2, NADPH itself enhanced 
the DNA-binding activity of NPAS2/BMAL1 heterodimer. Conversely, the 
DNA-complex formation of BMAL1 homodimer, which is not functional as a 
transcription factor, was not affected by pH and NADPH (Figure 3-6). In addition, the 
N-terminal 1-61 amino acids of NPAS2, which are adequate for heterodimer formation 
with BMAL1 and binding to E-box DNA, were sufficient for the effects of pH on its 
DNA-binding activity. The bHLH domain (1-61 a.a.) of NPAS2 was also responsible for 
the NADPH effect, as reported in the chapter 2-3-2, suggesting that pH and NADPH 
were sensed by a similar region of NPAS2. 
The KD
app
 values of the E-box DNA to 
NPAS2-bHLH-PASA/BMAL1-bHLH-PASA-PASB heterodimer were obtained at 
various pH values in the presence or absence of NADPH (Table 3-1), and changes in pH 
and NADPH concertedly decreased the KD
app
 value. Under experimental conditions in 
the present study, the KD
app
 values were between 9-125 nM. These values for 
NPAS2/BMAL1 heterodimer were comparable to those for other bHLH-PAS family 
proteins, such as human HIF-1α/HIF-1β (ARNT) and mouse-DR/human-ARNT 
heterodimers [63]. Gel-filtration analysis suggested that in the system of present study, 
BMAL1 bHLH-PASA-PASB formed a higher-order oligomer than a dimer, and NPAS2 
bHLH-PASA formed mainly dimers with a minor monomer fraction, indicating that all 
species of those existed in a dynamic equilibrium in solution. In the absence of NADPH, 
the mixture of NPAS2, BMAL1 and DNA revealed the partial formation of a 
heterodimer complex with DNA, and the addition of NADPH increased the formation 
of the heterodimer complex, with a decrease in BMAL1 oligomers (Figure 3-11). 
Therefore, under EMS conditions in the present study, it was postulated that formation 
of the complexes of DNA with BMAL1/BMAL1 homodimer and NPAS2/BMAL1 
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heterodimer were readily detectable though BMAL1 oligomer, NPAS2 oligomer, and 
NPAS2/NPAS2 homodimer did not form a detectable complex with DNA. Figure 3-9 
demonstrated that the NPAS2/BMAL1/DNA complex was preferentially formed, with a 
decrease in the BMAL1/BMAL1/DNA complex, even though the KD
app
 value of DNA 
to BMAL1 homodimer was smaller than that to NPAS2/BMAL1 heterodimer in the 
absence of NADPH and even in the presence of NADPH at a pH lower than 7.5. These 
results suggest that the formation of NPAS2/BMAL1 heterodimer was preferential to 
that of BMAL1 homodimer. 
Recently, the KD
app
 value of fluorescein-labeled E’-box DNA (CACGTT) to the 
murine CLOCK bHLH-PASA-PASB/BMAL1 bHLH-PASA-PASB heterodimer was 
reported to be 59 ± 7.3 nM by fluorescence anisotropy [53]. It was similar to the values 
of the NPAS2 bHLH-PASA/BMAL1 bHLH-PASA-PASB heterodimer obtained in this 
study, suggesting that the ability of the murine NPAS2/BMAL1 heterodimer to bind to 
the E-box DNA was comparable to the murine CLOCK/BMAL1 heterodimer. In 
contrast, the KD value of E-box DNA to the human CLOCK bHLH/BMAL1 bHLH 
heterodimer was also reported to be 1.52 ± 0.10 μM by ITC measurement at pH 7.8 [54], 
which was 30 and 70 times larger than the values obtained in this study at pH 7.5 and 
8.0, respectively (Table 3-1). These authors also reported that none of the NAD(P)H 
cofactors tested significantly affected the KD value of the E-box DNA to the human 
CLOCK bHLH/BMAL1 bHLH heterodimer [54]. Although the reasons for these 
differences were not clear, each experiment used different protein expression systems 
and analysis methods. Because the PAS domain is known to play an important role in 
dimer formation for various PAS proteins, the PAS domains contained in NPAS2 and 
BMAL1 constructs used in this study to evaluate KD
app
 values must have contributed to 
stabilizing NPAS2/BMAL1 heterodimer, resulting in an increase in its DNA-binding 
activity. 
Interestingly, the effects of pH were observed only for the complex formation of 
NPAS2/BMAL1 or CLOCK/BMAL1 heterodimers with E-box DNA, but not for that of 
BMAL1 homodimer with E-box DNA. In addition, considering that the bHLH domain 
of NPAS2 and CLOCK is sufficient to sense pH, therefore, the differences among the 
bHLH domain of CLOCK, NPAS2 and BMAL1 should be focused on (Figure 3-16). 
- 61 - 
 
Two groups recently reported the crystal structures of the bHLH-PASA-PASB domains 
of the murine (m) CLOCK/BMAL1 heterodimer [53] and the bHLH domains of the 
human (h) CLOCK/BMAL1 heterodimer bound to E-box DNA [54]. Based on the 
structure, Wang et al. demonstrated that His84 of hCLOCK and Leu125 of hBMAL1 
were critical residues involved in mutual recognition for heterodimer formation. His59, 
which is contained in construct of the bHLH domain of mNPAS2 (1-61 a.a.) as the only 
His, corresponds to His84 of hCLOCK. His has also been reported as a residue 
responsible for pH sensing among many pH sensor proteins, such as KcsA, ASIC1a and 
epithelial Na
+
 channel [64-66]. Therefore, His59 of NPAS2 is a possible candidate for 
sensing pH and for the formation of a stable heterodimer with BMAL1. Ser38 and 
Ser42 of mCLOCK, corresponding to Ser13 and Ser17 of mNPAS2, respectively, were 
reported to reduce transcriptional activity in vivo when phosphorylated [22], but neither 
the S38E nor S42E mutation of hCLOCK had a significant influence on DNA binding 
in vitro [54]. At the interface between the bHLH domains of CLOCK (NPAS2) and 
BMAL1, Ser70 of hCLOCK (Thr46 of mNPAS2), which is not conserved in the bHLH 
domain of BMAL1, appears to interact with Lys87 of hBMAL1 and mBMAL1 (Figure 
3-16). Ser70 also possibly affects heterodimer formation depending on pH. Further 
studies are required to elucidate the residues responsible for the effects of pH on NPAS2 
and CLOCK. 
In NIH3T3 cells, on the other hand, it was demonstrated that the 
NPAS2-dependent transcriptional activity of mPer1 increased with extracellular pH 
(from pH 6.8 to pH 7.7), whereas that of reporter containing all mutated E-boxes rather 
decreased (Figure 3-15). These results suggest that the transcriptional activity 
depending E-box/NPAS2 is significantly affected by pH change even within the range 
of physiological pH, although it is not clear whether pH effect is direct, and if so, how 
extracellular pH affects the intracellular and nuclear pH under these conditions. 
 
 
  
- 62 - 
 
 
 
Figure 3-16. Multiple sequence alignment of the bHLH domains of human CLOCK, 
murine CLOCK, murine NPAS2, murine BMAL1, and human BMAL1. The arrows 
represent amino acid residues, Ser38, Ser42, Ser70 and His84 of hCLOCK, and Lys87 
and Leu125 of hBMAL1 discussed in the text (A). Localization of the amino acids 
pointed in (A) in the structure of the bHLH DNA-binding domain of human 
CLOCK/BMAL1 heterodimer (PDB: 4H10) [54] (B). 
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Chapter 4. 
Summary and conclusion 
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Molecular rhythms in mammalian cells and tissues can be entrained by various 
extra- and intracellular stimuli, such as light, temperature, hormone, gaseous signaling 
molecules and metabolites. These stimuli simultaneously and concertedly act on clock 
machinery to reset behavioral and physiological rhythms. In the present study, it was 
demonstrated that pH as well as NADPH had effects on the DNA-binding and 
transcriptional activity of NPAS2, a mammalian circadian transcription factor acting as 
a positive limb of core loops in the clock. 
It has been suggested that the DNA-binding activity of NPAS2 is regulated by the 
intracellular redox state of NAD(P)H [51], although the mechanism remains unclear. In 
the chapter 2, EMS assays using several truncation mutants of the NPAS2 bHLH 
domain were performed to investigate the NAD(P)H interaction site of murine NPAS2. 
Among the mutants, NPAS2 containing the N-terminal 61 residues formed a 
heterodimer with BMAL1 to bind DNA, and NAD(P)H enhanced the binding activity, 
while NAD(P)H inhibited the DNA-binding activity of the BMAL1 homodimer in a 
dose-dependent manner. NAD(P)H derivatives such as 2’, 5’-ADP, nicotinamide, 
nicotinic acid and nicotinic acid adenine dinucleotide (NAAD) did not affect the 
DNA-binding activity. Interestingly, NAD(P)
+
, previously reported as an inhibitor, did 
not affect the DNA-binding activity of NPAS2 in the absence or presence of NAD(P)H 
in the system of present study. These results suggest that the DNA-binding activity of 
NPAS2 is specifically enhanced by NAD(P)H independently of NAD(P)
+
 and that the 
N-terminal 1-61 amino acids of NPAS2 are sufficient to sense NAD(P)H. 
On the other hand, it was reported that extracellular pH levels affect the 
expression rhythms of clock genes in cultured cells [57, 58]. In the chapter 3, therefore, 
the effects of pH on the DNA-binding activity of NPAS2 were investigated. In an EMS 
assay, the pH of the reaction mixture affected the DNA-binding activity of 
NPAS2/BMAL1 heterodimer but not that of BMAL1 homodimer. A change in pH from 
7.0 to 7.5 resulted in a 1.7-fold increase in activity in the absence of NADPH, and 
NADPH additively enhanced the activity up to 2.7-fold at pH 7.5. The experiments 
using truncation mutants revealed that the N-terminal 1-61 amino acids of NPAS2 were 
sufficient to sense both the pH change and NADPH. The kinetics of the formation and 
DNA-binding of the NPAS2/BMAL1 heterodimer at various pH values were further 
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analyzed. In the absence of NADPH, a pH change from 6.5 to 8.0 decreased the KD
app
 
value of the E-box to NPAS2/BMAL1 heterodimer from 125 to 22 nM, with an 8-fold 
increase in the maximum level of DNA-binding of the heterodimer. The addition of 
NADPH resulted in a further decrease in KD
app
 to 9 nM at pH 8.0. Taken together, both 
of NADPH and pH affects the equilibrium among BMAL1/BMAL1, NPAS2/NPAS2, 
NPAS2/BMAL1, and their complexes with the target DNAs as shown in Figure 4-1. 
 
Figure 4-1. Schematic diagram to show the equilibrium among BMAL1/BMAL1, 
NPAS2/NPAS2, NPAS2/BMAL1, and their complexes with the target DNAs. 
 
 
 
 
Furthermore, NPAS2-dependent transcriptional activity in a luciferase assay using 
NIH3T3 cells also increased with the pH of the culture medium. Although intracellular 
pH is generally strictly regulated within a narrow neutral region, it is known that the pH 
decreases in muscles after hard exercise due to the accumulation of pyruvate and lactate 
[67]. In cancer cells, extracellular acidification is caused by the enhancement of 
glycolysis that is sequentially followed by an increase in intracellular lactate and H
+
, the 
induction of some of ion channels and receptors, and the efflux of these acids [61]. By 
means of the measuring autofluorescence lifetime of NADH, it was also demonstrated 
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that the alteration of cytosol pH induced pH change in nuclei in culture cells [68]. 
Interestingly, the results in the present study are consistent with the results of two other 
reports indicating the effects of extracellular pH on circadian rhythm [57, 58]. Kon et al. 
reported that alkali signals triggered a resetting of the molecular clock in cultured Rat-1 
fibroblasts [57]. A pH shift in the culture medium in a range of 0.1–0.4 resulted in an 
increase in Dec1 mRNA and consequently the phase-shift of the cellular rhythm. It was 
also reported that a pH change of the culture medium from 6.7 to 7.2 affected both the 
amplitude and the phase of the circadian expression of the hBMAL1 reporter in human 
primary fibroblasts [58]. In summary, the balance between NAD(P)H and pH appears to 
be a cue for the regulation of clocks via NPAS2 (CLOCK) under the various 
physiological conditions of tissues and cells, although further experiments are needed to 
elucidate precise mechanisms for sensing these signals. 
 
Conclusions in the chapter 2. 
1. NAD(P)H enhances the DNA-binding activity of NPAS2/BMAL1 heterodimer, but 
inhibits that of BMAL1/BMAL1 homodimer. 
2. The N-terminal 1-61 amino acids of NPAS2 are sufficient to sense NAD(P)H. 
3. NAD(P)
+, 2’,5’-ADP, nicotinamide and NAAD do not affect the DNA-binding 
activity of NPAS2. 
 
Conclusions in the chapter 3 
1. The binding affinity of E-box to NPAS2/BMAL1 heterodimer increase with pH and 
additively by the presence of NADPH in vitro.  
2. The N-terminal 1-61 amino acids of NPAS2 are sufficient to sense pH and NADPH.  
3. NPAS2-dependent transcriptional activity regulating the mPer1 gene also increase 
with extracellular pH in culture cells. 
 
These results suggest that NPAS2 has a role as a pH and metabolite sensor to regulate 
circadian rhythms. 
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